(Q43786469)

26 November 2017

Reduced activity and protein expression of NOS in R6/2 HD transgenic mice: effects of L-NAME on symptom progression (English)

1 reference

26 November 2017

Deckel AW

1

1 reference

26 November 2017

Gordinier A

2

1 reference

26 November 2017

Nuttal D

3

1 reference

26 November 2017

Tang V

4

1 reference

26 November 2017

Kuwada C

5

1 reference

26 November 2017

Freitas R

6

1 reference

26 November 2017

Gary KA

7

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

26 November 2017

1 reference

26 November 2017

919

1 reference

26 November 2017

1

1 reference

26 November 2017

70-81

1 reference

Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903000-1

Immunohistochemically detected protein nitration indicates sites of renal nitric oxide release in Goldblatt hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903000-1

Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903000-1

Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903000-1

Nitric oxide and nitric oxide synthase in Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903000-1

Increased CBF velocity during word fluency in Huntington's disease patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903000-1

Cerebral blood flow velocity decreases during cognitive stimulation in Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903000-1

Vasomotor hyporeactivity in the anterior cerebral artery during motor activation in Huntington's disease patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903000-1

Dietary arginine alters time of symptom onset in Huntington's disease transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903000-1

Role of nitric oxide in the coupling of cerebral blood flow to neuronal activation in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903000-1

Mechanisms of cell death governed by the balance between nitrosative and oxidative stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903000-1

Selective sparing of a class of striatal neurons in Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903000-1

Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903000-1

Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903000-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903000-1

Analytical methods for 3-nitrotyrosine as a marker of exposure to reactive nitrogen species: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903000-1

A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903000-1

Bright and dark sides of nitric oxide in ischemic brain injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903000-1

Nitric oxide synthase inhibition and cerebrovascular regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903000-1

Biphasic regulation of leukocyte superoxide generation by nitric oxide and peroxynitrite

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903000-1

Intranuclear huntingtin increases the expression of caspase-1 and induces apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903000-1

A huntingtin-associated protein enriched in brain with implications for pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903000-1

Decreased expression of striatal signaling genes in a mouse model of Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903000-1

Huntington's disease. Pathogenesis and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903000-1

A discussion of the chemistry of oxidative and nitrosative stress in cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903000-1

Clinical and neuropathologic assessment of severity in Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903000-1

Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903000-1

Mutant huntingtin forms in vivo complexes with distinct context-dependent conformations of the polyglutamine segment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903000-1

Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903000-1

Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903000-1

Huntington disease: Clinical care and evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903000-1

The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903000-1

Nitric oxide in cerebral ischemic neurodegeneration and excitotoxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903000-1

Quantification of a neurotrophin receptor from submilligram quantities of brain tissue using western blotting.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903000-1

Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903000-1

Analysis of the neuroprotective effects of various nitric oxide donor compounds in murine mixed cortical cell culture.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903000-1

HIP-I: a huntingtin interacting protein isolated by the yeast two-hybrid system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903000-1

Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903000-1

Nitric oxide protects against alkyl peroxide-mediated cytotoxicity: further insights into the role nitric oxide plays in oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903000-1

Antioxidant effects of nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903000-1

Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903000-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Neuropathological classification of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903000-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-8993(01)03000-1

1 reference

26 November 2017

1 reference